Cargando…

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis

BACKGROUND AND AIMS: The serum/plasma proteome was explored for biomarkers to improve the diagnostic ability of CA19-9 in pancreatic adenocarcinoma (PC). METHODS: A Training Set of serum samples from 20 resectable and 18 stage IV PC patients, 54 disease controls (DCs) and 68 healthy volunteers (HVs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, A, Scarlett, C J, Chung, L, Butturini, G, Scarpa, A, Gandy, R, Wilson, S R, Baxter, R C, Smith, R C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920018/ https://www.ncbi.nlm.nih.gov/pubmed/20588270 http://dx.doi.org/10.1038/sj.bjc.6605764

Ejemplares similares

Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma
por: Xue, A, et al.
Publicado: (2012)

In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery
por: Zhang, Jian, et al.
Publicado: (2017)

Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling
por: Atrih, A, et al.
Publicado: (2014)

Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
por: Anderson, K S, et al.
Publicado: (2011)

iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance
por: Tonack, S, et al.
Publicado: (2013)

Identification of serum biomarkers for colon cancer by proteomic analysis
por: Ward, D G, et al.
Publicado: (2006)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
por: Handra-Luca, A, et al.
Publicado: (2011)

Ascites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine
por: Golan, T, et al.
Publicado: (2014)

Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study
por: Larkin, S E T, et al.
Publicado: (2016)

Tissue biomarkers of breast cancer and their association with conventional pathologic features
por: Chung, L, et al.
Publicado: (2013)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2009)

Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models
por: Ligat, Laetitia, et al.
Publicado: (2015)

Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
por: Ankeny, J S, et al.
Publicado: (2016)

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
por: Dive, C, et al.
Publicado: (2010)

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
por: Khoja, L, et al.
Publicado: (2012)

Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
por: Boeck, S, et al.
Publicado: (2013)

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy
por: Maeda, J, et al.
Publicado: (2008)

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients
por: Tonini, G, et al.
Publicado: (2005)

Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells
por: Kaistha, B P, et al.
Publicado: (2014)

Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags
por: Sogawa, Kazuyuki, et al.
Publicado: (2016)

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone
por: Wasan, H S, et al.
Publicado: (2009)

Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease
por: Reis, I M, et al.
Publicado: (2015)

mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma
por: Baren, J P, et al.
Publicado: (2012)

Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer
por: Kuefer, R, et al.
Publicado: (2005)

Proteomic profiling of the hypothalamus in a mouse model of cancer-induced anorexia-cachexia
por: Ihnatko, R, et al.
Publicado: (2013)

Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib
por: Pommier, A J C, et al.
Publicado: (2014)

Preclinical and post-treatment changes in the HCC-associated serum proteome
por: Ward, D G, et al.
Publicado: (2006)

Endostatin expression in pancreatic tissue is modulated by elastase
por: Brammer, R D, et al.
Publicado: (2005)

Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
por: Shipitsin, M, et al.
Publicado: (2014)

hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
por: Lastraioli, E, et al.
Publicado: (2015)

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
por: McCormick Matthews, L H, et al.
Publicado: (2015)

Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
por: Cocco, E, et al.
Publicado: (2009)

Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics
por: Wang, W, et al.
Publicado: (2014)

Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells
por: Liau, S-S, et al.
Publicado: (2007)

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
por: Smith, R A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rkrrbt0um1ci9nhag8hq4j3td5